Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung CancerShun Lü, Xiaosheng Hang, Peng Zhang et al.|JAMA|2024Cited by 359
366 A randomized double-blind placebo-controlled phase III study evaluating perioperative toripalimab combined with platinum-based doublet chemotherapy in resectable stage III NSCLCWenxiang Wang, Tao Xu, Lin Wu et al.|Regular and Young Investigator Award Abstracts|2020Cited by 2